Prevenar 20 (previously Apexxnar)
pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)
Pneumococcal Infections
Date of authorisation:
Revision: 8
Last updated:
MedicineHumanAuthorised
Prevenar 13
pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed)
Pneumococcal Infections
Immunization
Date of authorisation:
Revision: 47
Last updated:
MedicineHumanAuthorised
EMEA-003155-PIP01-21 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Vaccines
PIP number: P/0485/2022
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Solution for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Infanrix Hexa
diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed)
Hepatitis B
Tetanus
Immunization
Meningitis, Haemophilus
Whooping Cough
Poliomyelitis
Diphtheria
Date of authorisation:
Revision: 47
Last updated:
MedicineHumanAuthorised
Infanrix Penta
diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) vaccine (adsorbed)
Hepatitis B
Tetanus
Immunization
Whooping Cough
Poliomyelitis
Diphtheria
Date of authorisation:
Revision: 13
Last updated:
MedicineHumanLapsed
EMEA-000036-PIP01-07-M06 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Vaccines
PIP number: P/0161/2012
Route(s) of administration: Intramuscular use
Pharmaceutical form(s):
Suspension for injection
Decision date:
Last updated:
Compliance check: ✔
PIPHuman